Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis

BACKGROUND: A high-dose trivalent inactivated influenza vaccine was licensed in 2009 by the US Food and Drug Administration (FDA) on the basis of serological criteria. We sought to establish whether high-dose inactivated influenza vaccine was more effective for prevention of influenza-related visits...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Lancet Infect Dis
Hauptverfasser: Izurieta, Hector S, Thadani, Nicole, Shay, David K, Lu, Yun, Maurer, Aaron, Foppa, Ivo M, Franks, Riley, Pratt, Douglas, Forshee, Richard A, MaCurdy, Thomas, Worrall, Chris, Howery, Andrew E, Kelman, Jeffrey
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2015
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4834448/
https://ncbi.nlm.nih.gov/pubmed/25672568
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1473-3099(14)71087-4
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge